Bryan Johnson

In 2016, Bryan announced that he was investing $100M into his new company Kernel to build advanced neural interfaces to treat disease and dysfunction, illuminate the mechanisms of intelligence, and extend cognition. Kernel is on a mission to dramatically increase our quality of life as healthy lifespans extend. He believes that the future of humanity will be defined by the combination of human and artificial intelligence (HI +AI).

In 2014, Bryan invested $100M to start OS Fund to support inventors and scientists who aim to benefit humanity by rewriting the operating systems of life. His OS Fund investments include endeavors to cure age-related diseases and radically extend healthy human life to 100+, make biology a predictable programming language, digitize analog businesses, replicate the human visual cortex using artificial intelligence, expand humanity’s access to resources, reinvent transportation using autonomous vehicles, and reimagine food using biology, among others.

In 2007, Bryan founded Braintree, an online and mobile payments provider, that was acquired in 2013 by PayPal for $800M.

Bryan is an outdoor-adventure enthusiast, pilot, and author of a children’s book, Code 7.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.